Skip to main content

Table 3 Comparison of erosion volume and bone parameters by high-resolution peripheral quantitative computed tomography between baseline and 3 months in each treatment group

From: Assessment of 3-month changes in bone microstructure under anti-TNFα therapy in patients with rheumatoid arthritis using high-resolution peripheral quantitative computed tomography (HR-pQCT)

Total (n = 19)

MTX-only group (n = 9)

MTX + anti-TNFα group (n = 13)

Mean ± SD

Baseline

3 Months

Changes (A)

p value*

Baseline

3 Months

Changes (A)

p value*

MCP2

 Erosion number (n)

7

7

  

23

23

  

 Erosion volume (mm3)

6.7 ± 6.4

7.5 ± 6.4

0.9 ± 0.5

0.006

41.4 ± 65.5

37.6 ± 60.3

-3.8 ± 5.2

0.048

Joint space

        

 Width (mm)

1.81 ± 0.14

1.80 ± 0.13

-0.01 ± 0.07

0.705

1.87 ± 0.20

1.80 ± 0.15

-0.07 ± 0.09

0.028

 Volume (mm3)

133.6 ± 17.3

134.6 ± 16.0

1.0 ± 5.5

0.606

125.4 ± 20.5

118.7 ± 17.0

-6.68 ± 7.08

0.001

MCH2 microarchitecture BMD (mg/cm3)

 Total

279.9 ± 34.2

277.4 ± 40.2

-6.2 ± 16.1

0.288

316.2 ± 34.7

327.8 ± 45.9

11.6 ± 33.0

0.268

 Trabecular

236.2 ± 26.9

233.6 ± 33.2

-2.6 ± 20.4

0.731

259.0 ± 25.6

266.9 ± 41.0

7.8 ± 26.8

0.353

MCP3

 Erosion number (n)

4

4

  

13

13

  

 Erosion volume (mm3)

2.3 ± 11.5

3.1 ± 1.2

0.8 ± 0.5

0.019

21.6 ± 31.5

18.9 ± 29.0

-2.7 ± 2.5

0.014

 Joint space

        

  Width (mm)

1.72 ± 0.14

1.74 ± 0.15

0.02 ± 0.05

0.226

1.83 ± 0.12

1.74 ± 0.14

-0.10 ± 0.07

0.001

  Volume (mm3)

138.9 ± 17.0

142.1 ± 20.2

3.2 ± 4.3

0.069

131.9 ± 24.1

125.6 ± 21.4

-4.3 ± 4.6

0.003

 MCH3 microarchitecture BMD (mg/cm3)

        

  Total

279.9 ± 28.0

280.8 ± 25.0

1.0 ± 7.0

0.706

324.5 ± 35.7

321.8 ± 34.8

-2.7 ± 8.4

0.298

  Trabecular

238.9 ± 20.1

241.9 ± 18.1

3.0 ± 8.1

0.322

269.4 ± 26.7

267.6 ± 26.1

-1.7 ± 8.5

0.513

Distal radius

 Erosion number (n)

15

15

  

11

11

  

 Erosion volume (mm3)

21.1 ± 26.4

23.4 ± 29.1

1.6 ± 3.3

0.075

199.9 ± 362.6

188.4 ± 331.4

-15.5 ± 31.7

0.211

 Joint space

        

  Width (mm3)

2.04 ± 0.24

2.04 ± 0.18

-0.01 ± 0.12

0.981

2.09 ± 0.29

2.11 ± 0.29

0.01 ± 0.17

0.758

  Volume (mm3)

249.8 ± 29.3

261.1 ± 30.5

11.3 ± 22.3

0.197

247.5 ± 67.1

240.2 ± 71.2

-7.3 ± 25.0

0.356

 Wrist microarchitecture BMD (mg/cm3)

        

  Total

272.3 ± 61.3

272.8 ± 60.3

0.6 ± 4.3

0.709

356.0 ± 58.6

354.0 ± 58.4

-2.0 ± 7.1

0.357

  Cortical

793.7 ± 82.9

792.1 ± 83.2

-1.6 ± 9.8

0.663

873.4 ± 42.7

874.9 ± 43.7

1.5 ± 9.7

0.607

  Trabecular

148.0 ± 31.0

148.6 ± 30.8

0.6 ± 2.7

0.543

174.5 ± 53.7

172.0 ± 51.2

-2.5 ± 5.1

0.115

 Cortical thickness (μm)

607.8 ± 200.4

606.7 ± 199.5

3.8 ± 21.2

0.900

824.6 ± 142.7

830.8 ± 140.8

6.2 ± 27.3

0.450

 Trabecular

        

  Number

1.82 ± 0.14

1.80 ± 0.17

-0.02 ± 0.15

0.748

1.97 ± 0.45

1.94 ± 0.42

-0.03 ± 0.10

0.315

  Thickness (μm)

68.9 ± 12.6

69.9 ± 12.6

1.4 ± 5.0

0.441

72.9 ± 10.8

73.1 ± 10.2

0.2 ± 4.1

0.898

  Separation (μm)

485.7 ± 51.1

491.2 ± 60.0

5.6 ± 45.6

0.740

471.5 ± 171.7

475.1 ± 156.3

3.6 ± 34.8

0.725

  1. The distal radius joint space was measured at the radio-lunar joint. MTX methotrexate, TNFa tumor necrosis factor alpha, MCH metacarpal heads, BMD bone mineral density. *Paired t test. Bold characters mean p < 0.05